ASX Share rice
Tue 18 May 2021 - 12:41:pm (Sydney)

API Share Price

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITEDAPIHealth Care Equipment & Services

API Company Information

Name:

Australian Pharmaceutical Industries Limited

Sector:

Healthcare

Industry:

Medical Distribution

GIC Industry:

Health Care Providers & Services

GIC Sub Industry:

Health Care Distributors

Address:

250 Camberwell Road Camberwell VIC Australia 3124

Phone:

61 3 8855 3000

MD, CEO & Exec. Director:

Mr. Richard C. Vincent C.P.A., B.Bus, (Accountancy), CPA

Chief Financial Officer:

Mr. Peter Mendo

Chief Information Officer:

Mr. Dean Matthews

Gen. Counsel & Company Sec.:

Ms. Anne Mustow B.Com., L.L.B.

Gen. Mang. of People:

Mr. Stephen Arthurson

NSW State Mang.:

Mr. D. Glance

Company Overview:

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.

API Share Price Information

Shares Issued:

492.66M

Market Capitalisation:

$537M

Dividend per Share:

$0.035

Ex Dividend Date:

2021-05-06

Dividend Yield:

3.21%

Revenue (TTM):

$3.97B

Revenue Per Share (TTM):

$8.05

Earnings per Share:

$0.106

Profit Margin:

-0.0036

Operating Margin (TTM):

$0.01

Return On Assets (TTM):

$0.02

Return On Equity (TTM):

$-0.03

Quarterly Revenue Growth (YOY):

-0.026

Gross Profit(TTM):

$480.47M

Diluted Earnings Per Share (TTM):

$-0.029

QuarterlyEarnings Growth(YOY):

-0.273

API CashFlow Statement

CashFlow Date:

2020-08-31

Investments:

$80.98M

Change To Liabilities:

$-87,211,000

Total Cashflow From Investing Activities:

$51.13M

Net Borrowings:

$-219,144,000

Net Income:

$-8,395,000

Total Cash From Operating Activities:

$215.52M

Depreciation:

$74.25M

Other Cashflow From Investing Activities:

$1.37M

Dividends Paid:

$-19,706,000

Change To Inventory:

$45.08M

Change To Account Receivables:

$155.04M

Capital Expenditures:

$39.99M

API Income Statement

Income Date:

2020-08-31

Income Before Tax:

$-14,647,000

Net Income:

$-8,395,000

Gross Profit:

$479.94M

Operating Income:

$4.43M

Other Operating Expenses:

$-7,479,000

Interest Expense:

$-8,962,000

Income Tax Expense:

$-6,710,000

Total Revenue:

$4.02B

Cost Of Revenue:

$3.55B

API Balance Sheet

Balance Sheet Date:

2020-08-31

Intangible Assets:

$140.21M

Total Liabilities:

$1.09B

Total Stockholder Equity:

$453.90M

Other Current Liabilities:

$19.15M

Total Assets:

$1.54B

Common Stock:

$566.46M

Other Current Assets:

$6.53M

Retained Earnings:

$-54,141,000

Other Liabilities:

$40.33M

Good Will:

$127.91M

Other Assets:

$66.11M

Cash:

$60.71M

Total Current Liabilities:

$832.68M

Short-Term Debt:

$8.26M

Property - Plant & Equipment:

$234.90M

Net Tangible Assets:

$186.45M

Long-Term Investments:

$1.20M

Total Current Assets:

$0.97B

Long-Term Debt:

$70.42M

Net Receivables:

$544.43M

Short-Term Investments:

$569.65M

Inventory:

$368.18M

Accounts Payable:

$741.95M

Short-Term Investments:

$569.65

Non Current Liabilities Total:

$252.54M

API Share Price History

API News

01 May, 2021
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Australian...
24 Apr, 2021
Last week, you might have seen that Australian Pharmaceutical Industries Limited ( ASX:API ) released its half-year...
06 Mar, 2021
If you want to know who really controls Australian Pharmaceutical Industries Limited ( ASX:API ), then you'll have to...
05 Jan, 2021
While it may not be enough for some shareholders, we think it is good to see the Australian Pharmaceutical Industries...
06 Nov, 2020
It looks like Australian Pharmaceutical Industries Limited (ASX:API) is about to go ex-dividend in the next four days...
20 Oct, 2020
Today we will run through one way of estimating the intrinsic value of Australian Pharmaceutical Industries Limited...
20 Sep, 2020
If you want to know who really controls Australian Pharmaceutical Industries Limited (ASX:API), then you'll have to...
22 Aug, 2020
With its stock down 2.2% over the past week, it is easy to disregard Australian Pharmaceutical Industries (ASX:API...
23 Jul, 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
10 Jun, 2020
Half Year 2020 Australian Pharmaceutical Industries Ltd Earnings Call

API Dividend Payments

EX-Date Dividend Amount
2010-05-07$0.0100
2010-11-05$0.0150
2011-05-04$0.0100
2011-11-11$0.0150
2012-05-04$0.0150
2012-11-12$0.0150
2013-05-06$0.0150
2013-11-11$0.0175
2014-05-07$0.0150
2014-11-12$0.0200
2015-05-06$0.0200
2015-11-04$0.0250
2016-05-05$0.0250
2016-11-03$0.0350
2017-05-04$0.0350
2017-11-09$0.0350
2018-05-03$0.0350
2018-11-08$0.0400
2019-05-02$0.0375
2019-11-13$0.0400
2020-11-11$0.0200
2021-05-06$0.0150

API Dividends (last 12 Years)